231 related articles for article (PubMed ID: 38702756)
1. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
2. Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.
Xu M; Hou Y; Li N; Yu W; Chen L
J Transl Med; 2024 May; 22(1):418. PubMed ID: 38702756
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
He L; Gao L; Shay C; Lang L; Lv F; Teng Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):84. PubMed ID: 30777099
[TBL] [Abstract][Full Text] [Related]
4. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
5. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
7. Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
Atri S; Nasoohi N; Hodjat M
Curr Mol Pharmacol; 2021; 14(1):60-67. PubMed ID: 32394848
[TBL] [Abstract][Full Text] [Related]
8. A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.
Iwasa YI; Nakajima T; Hori K; Yokota Y; Kitoh R; Uehara T; Takumi Y
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136558
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Nano-Based Photodynamic Treatment as a Therapy against Oral Leukoplakia: A Narrative Review.
Angjelova A; Jovanova E; Polizzi A; Santonocito S; Lo Giudice A; Isola G
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959284
[TBL] [Abstract][Full Text] [Related]
10. The Dual Functions of Andrographolide in the Epstein-Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein-Barr Virus and the Induction of Cell Death.
Heawchaiyaphum C; Malat P; Pientong C; Roytrakul S; Yingchutrakul Y; Aromseree S; Suebsasana S; Mahalapbutr P; Ekalaksananan T
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958849
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma.
Deng SZ; Wu X; Tang J; Dai L; Cheng B
Front Mol Biosci; 2023; 10():1185832. PubMed ID: 37705968
[No Abstract] [Full Text] [Related]
12. Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide.
Arboleda LPA; de Carvalho GB; Santos-Silva AR; Fernandes GA; Vartanian JG; Conway DI; Virani S; Brennan P; Kowalski LP; Curado MP
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686681
[TBL] [Abstract][Full Text] [Related]
13. Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer.
Shao B; Ye Z; Sun B; Xiao Z
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509156
[TBL] [Abstract][Full Text] [Related]
14. HDAC-an important target for improving tumor radiotherapy resistance.
Ling R; Wang J; Fang Y; Yu Y; Su Y; Sun W; Li X; Tang X
Front Oncol; 2023; 13():1193637. PubMed ID: 37503317
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
